RxDoctor Payments Data
★ My doctorsLook up a doctor →

Said Elshihabi, MD

Neurological Surgery · Marietta, GANPI 1467477463

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $396,712 of the $409,003 with a category attached, or 97.0%. Centinel Spine, LLC accounts for 91.8% of it on its own, with 57 other manufacturers making up the rest. Reporting peaked in 2021 at $104,557 and has fallen 99.1% since, to $898 in 2025. Among neurological surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$409,003in general payments, 2019–2025

Across 240 payments — averaging $1704.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Centinel Spine, LLC$375K
  • Silony Medical Corp.$23K
  • The Institute Of Musculoskeletal Science And Education$2K
  • Boston Scientific$2K
  • Si-bone, Inc.$1K
  • Spineology Inc.$499
  • plus $5K from 52 others
$379,682in research payments, 2019–2025

Across 16 payments — averaging $23,730 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spineart SA$337K
  • Spineart USA Inc$30K
  • Centinel Spine, LLC$13K

What the payments were for

  • Royalty or licence$396,71297%
  • Consulting fees$4,3751%
  • Travel & lodging$1,0010%
  • Food & beverage$6,9042%
  • Education$110%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Centinel Spine, LLC43$375,469
Silony Medical Corp.1$23,402
The Institute Of Musculoskeletal Science And Education2$2,060
Boston Scientific50$2,032
Si-bone, Inc.2$1,025
Spineology Inc.7$499
AbbVie22$397
Medtronic(2 entities)7$352
Abbott7$323
Livanova USA, Inc.2$295
VGI Medical, LLC1$271
Camber Spine Technologies LLC1$228
Kyocera Medical Technologies, Inc.4$219
Surgalign Spine Technologies, Inc.3$156
Intrinsic Therapeutics1$155
Providence Medical Technology, Inc.2$147
Spine Wave, Inc.2$138
Arbor Pharmaceuticals, Inc.11$130
GT Medical Technologies, Inc1$115
AstraZeneca5$107
Ossdsign USA Incorporated2$107
Johnson & Johnson(2 entities)5$103
Pfizer4$102
Amgen3$95
Arteriocyte Medical Systems, Inc.1$76
Teva Pharmaceuticals USA, Inc.3$65
Axsome Therapeutics, Inc.2$61
Bioventus LLC3$61
Portola Pharmaceuticals, LLC3$58
4web, Inc.2$57
Globus Medical3$47
Azurity Pharmaceuticals, Inc.2$42
Zimmer Biomet3$39
Biotronik NRO, Inc.2$39
Cerapedics Inc.1$37
Misonix Inc2$36
Xtant Medical Inc1$34
Baxter Healthcare1$33
Chiesi USA, Inc.2$30
Theragen, Inc.2$30
Neuros Medical, Inc.1$28
Lundbeck LLC1$27
Stryker1$25
Aesculap, Inc.1$25
Spinal Simplicity, LLC1$22
Flowonix Medical Incorporated1$22
Upsher-smith Laboratories LLC1$20
Lilly USA, LLC1$19
Impel Pharmaceuticals Inc.1$19
Trackx Technology, Inc.1$19
Electronic Waveform Lab, Inc.2$18
Pacira Pharmaceuticals Incorporated1$16
Argenx US, Inc.1$14
Integra Lifesciences Corporation1$13
Amneal Pharmaceuticals LLC1$13
Assertio Therapeutics, Inc.1$12
Merit Medical Systems Inc1$11
Lemaitre Vascular, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$409,003 in reported general payments places this provider in the 90th percentile of 201 neurological surgery providers in Georgia.

See all neurological surgery providers in Georgia →

Medicare billing

Part B allowed, 2024
$204,652
Medicare patients
289
Services billed
1,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant48$76,709
QuliptaAtogepant45$48,489
Nurtec OdtRimegepant Sulfate22$41,115
Pregabalin202$4,506
Memantine Hcl29$2,713
Gabapentin112$914
Divalproex Sodium41$682
Tizanidine Hcl118$550
Diclofenac Sodium25$482
Celecoxib18$478
Cyclobenzaprine Hcl93$476
Methocarbamol48$331
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$253
Meloxicam130$231
Amitriptyline Hcl14$225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$397$125,19893 claims
PfizerNurtec Odt$102$41,11522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 201 neurological surgery providers in Georgia.

Other neurological surgery in Marietta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →